比较扩大罗德岛社区纳洛酮分发策略的预期致死性过量结局与成本
该决策分析模型研究基于罗德岛2016年1月至2022年12月数据,构建空间微模拟模型与决策树,模拟63131名阿片过量风险个体,比较每年额外分发10000份纳洛酮的不同策略。需求导向、聚焦注射吸毒者的策略最优,估计每年避免25.3%(95%模拟区间13.1%-37.6%)的目击性过量死亡,增量成本最低,为每避免一例过量死亡27312美元。供给导向下优先使用非法药物者避免18.9%(95%模拟区间13.1%-30.7%)。需求导向方法在所有情景下均降低地理健康不平等。
要点
- 需求导向、聚焦注射吸毒者策略每年避免25.3%(95%模拟区间13.1%-37.6%)目击性过量死亡,增量成本最低(每避免一例27312美元)。
- 供给导向下优先使用非法药物者每年避免18.9%(95%模拟区间13.1%-30.7%)目击性过量死亡。
- 需求导向方法在所有情景下均较供给导向和现状降低过量死亡率的地理不平等。
- 其他策略避免的过量死亡更少且成本更高,但若能将试剂盒重新分配到需求更大地区,则呈现相似结局改善和单位成本降低模式。
- 作者认为,未来应优先关注最高过量风险人群(注射吸毒者或使用非法药物者),并将资源转向需求最大地区。
适用人群与场景
- 罗德岛所有有阿片过量风险的个体,基于当前人口数据模拟共63131人。
处置流程与药物剂量
- 每年额外分发10000份纳洛酮试剂盒,可针对注射吸毒者、使用非法阿片和兴奋剂者、不同过量风险水平个体或误用处方阿片者,对比不额外分发(现状)。
- 两种扩增实施方法:供给导向法(与各分发项目类型当前空间分布模式一致)和需求导向法(与各风险组个体当前空间分布一致,假定项目可在需要时将额外试剂盒导向新地理区域)。
研究设计与关键结果
- 研究类型:决策分析模型研究,开发空间微模拟模型并整合决策树,校准以比较替代策略结局,研究期间2016年1月至2022年12月。
- 模拟63131名阿片过量风险个体;供给导向下优先使用非法药物者每年避免目击性过量死亡的估计均值为18.9%(95%模拟区间13.1%-30.7%)。
- 需求导向下聚焦注射吸毒者在所有情景中结局最佳,每年避免目击性过量死亡的估计均值为25.3%(95%模拟区间13.1%-37.6%),增量成本最低,为每避免一例过量死亡27312美元。
- 其他策略避免的过量死亡更少且成本更高,但若试剂盒可重新分配到需求更大地区,则呈现相似结局改善和单位成本降低模式。
- 需求导向方法在所有情景下均较供给导向方法和现状降低过量死亡率的地理不平等。
证据类型、等级与局限
- 证据类型:决策分析模型研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来努力应优先关注最高过量风险人群(注射吸毒者或使用非法药物者),并将资源转向需求最大地区。
- 这些发现可能为未来纳洛酮分发优先设置提供信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: In 2021, the state of Rhode Island distributed 10 000 additional naloxone kits compared with the prior year through partnerships with community-based organizations.
OBJECTIVE: To compare various strategies to increase naloxone distribution through community-based programs in Rhode Island to identify one most effective and efficient strategy in preventing opioid overdose deaths (OODs).
DESIGN, SETTING, AND PARTICIPANTS: In this decision analytical model study conducted from January 2016 to December 2022, a spatial microsimulation model with an integrated decision tree was developed and calibrated to compare the outcomes of alternative strategies for distributing 10 000 additional naloxone kits annually among all individuals at risk for opioid overdose in Rhode Island.
INTERVENTIONS: Distribution of 10 000 additional naloxone kits annually, focusing on people who inject drugs, people who use illicit opioids and stimulants, individuals at various levels of risk for opioid overdose, or people who misuse prescription opioids vs no additional kits (status quo). Two expanded distribution implementation approaches were considered: one consistent with the current spatial distribution patterns for each distribution program type (supply-based approach) and one consistent with the current spatial distribution of individuals in each of the risk groups, assuming that programs could direct the additional kits to new geographic areas if required (demand-based approach).
MAIN OUTCOMES AND MEASURES: Witnessed OODs, cost per OOD averted (efficiency), geospatial health inequality measured by the Theil index, and between-group variance for OOD rates.
RESULTS: A total of 63 131 simulated individuals were estimated to be at risk for opioid overdose in Rhode Island based on current population data. With the supply-based approach, prioritizing additional naloxone kits to people who use illicit drugs averted more witnessed OODs by an estimated mean of 18.9% (95% simulation interval [SI], 13.1%-30.7%) annually. Expanded naloxone distribution using the demand-based approach and focusing on people who inject drugs had the best outcomes across all scenarios, averting an estimated mean of 25.3% (95% SI, 13.1%-37.6%) of witnessed OODs annually, at the lowest mean incremental cost of $27 312 per OOD averted. Other strategies were associated with fewer OODs averted at higher costs but showed similar patterns of improved outcomes and lower unit costs if kits could be reallocated to areas with greater need. The demand-based approach reduced geospatial inequality in OOD rates in all scenarios compared with the supply-based approach and status quo.
CONCLUSIONS AND RELEVANCE: In this decision analytical model study, variations in the effectiveness, efficiency, and health inequality of the different naloxone distribution expansion strategies and approaches were identified. Future efforts should be prioritized for people at highest risk for overdose (those who inject drugs or use illicit drugs) and redirected toward areas with the greatest need. These findings may inform future naloxone distribution priority settings.
参考来源
- Zang X, Bessey SE, Krieger MS, et al. Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island. JAMA Netw Open. 2022. PMID: 36350649. doi:10.1001/jamanetworkopen.2022.41174
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。